The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Globus Medical Inc shares valued at $590,100 were sold by RHOADS ANN D on Feb 28 ’25. At $78.68 per share, RHOADS ANN D sold 7,500 shares. The insider’s holdings dropped to 35,384 shares worth approximately $2.07 million following the completion of this transaction.
Also, RHOADS ANN D purchased 7,500 shares, netting a total of over 590,000 in proceeds.
Before that, Pfeil Keith W had sold 14,167 shares from its account. In a trade valued at $1,250,770, the COO, CFO traded Globus Medical Inc shares for $88.29 each. Upon closing the transaction, the insider’s holdings decreased to 14,167 shares, worth approximately $0.0.
As published in a research note from BofA Securities on January 10, 2025, Globus Medical Inc [GMED] has been rated up from an Underperform to a Neutral and the price target has been revised to $97. Analysts at Morgan Stanley upgraded the stock from ‘”an Equal-weight”‘ to ‘”an Overweight”‘ outlook in a report released in early December. As of August 07, 2024, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for GMED. Earlier on May 20, 2024, Piper Sandler upgraded its rating. Their new recommendation was “an Overweight” for GMED stock which previously was a “a Neutral”.
Analyzing GMED Stock Performance
During the last five days, there has been a surge of approximately 1.35%. Over the course of the year, Globus Medical Inc shares have dropped approximately -29.15%. Shares of the company reached a 52-week high of $94.93 on 01/30/25 and a 52-week low of $54.48 on 05/09/25.
Support And Resistance Levels for Globus Medical Inc (GMED)
According to the 24-hour chart, there is a support level at 58.08, which, if violated, would cause prices to drop to 57.56. In the upper region, resistance lies at 59.23. The next price resistance is at 59.86. RSI (Relative Strength Index) is 34.77 on the 14-day chart, showing neutral technical sentiment.
